Israel Discount Bank of New York’s Jazz Pharmaceuticals JAZZ Stock Holding History

Israel Discount Bank of New York’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-320	Closed	-$46K	–	221
2019 Q1	$46K	Hold	320	–	–	0.03%	226
2018 Q4	$40K	Buy	320 +10	+3%	+$1.48K	0.03%	234
2018 Q3	$52K	Sell	310 -250	-45%	-$43K	0.03%	200
2018 Q2	$96K	Hold	560	–	–	0.06%	129
2018 Q1	$85K	Hold	560	–	–	0.06%	154
2017 Q4	$75K	Hold	560	–	–	0.05%	181
2017 Q3	$82K	Buy	560 +100	+22%	+$15.1K	0.06%	167
2017 Q2	$72K	Sell	460 -115	-20%	-$17.6K	0.06%	187
2017 Q1	$83K	Sell	575 -100	-15%	-$13K	0.07%	146
2016 Q4	$74K	Buy	+675	New	+$75.2K	0.07%	185

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Israel Discount Bank of New York's JAZZ Position: Q2 2019 in Review

Israel Discount Bank of New York sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2019, closing a stake of 320 shares — an estimated $46K sold.

Israel Discount Bank of New York first reported a position in JAZZ in Q4 2016 and held it in 10 quarters. The position peaked at $96K in Q2 2018. 416 funds tracked by Wall St. Rank hold JAZZ as of Q2 2019.

Israel Discount Bank of New York reported no remaining Jazz Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Israel Discount Bank of New York sold 320 Jazz Pharmaceuticals shares in Q2 2019, an estimated $46K.
Israel Discount Bank of New York first reported a position in Jazz Pharmaceuticals in Q4 2016 and held it in 10 quarters.
Israel Discount Bank of New York's Jazz Pharmaceuticals position peaked at $96K in Q2 2018.
416 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2019.

Based on Israel Discount Bank of New York's 13F filing for Q2 2019, filed 14 Aug 2019.